Ecomax P/FCF

Mitä Ecomax tekee? Ecomax Inc, trading under the ticker EMAX with ISIN US27889C3007, is a company headquartered in New York City, United States. The company went public via an IPO on July 12, 2001. Ecomax Inc engages in the search for new business opportunities, though specific details about its operations, products, or services are not provided in the available information. The company operates within a sector and industry that are listed as N/A, indicating no specific classification is assigned. There is no mention of founding year, key personnel, acquisitions, or financial figures beyond the IPO date. The source description includes unrelated information about Rocitin NMN, a nutritional supplement manufactured by a German company, and details about NMN (β-Nicotinamide Mononucleotide), which is described as a naturally occurring molecule in life forms that can be converted to NAD+ within cells. This information pertains to NMN research and its potential health benefits, including anti-aging properties and effects on DNA repair and cellular function. However, this content is not directly related to Ecomax Inc's business activities, as the company is not described as being involved in the production or research of NMN or related supplements. The company's focus remains on identifying new business opportunities without further elaboration on its current or past ventures. Ecomax on yksi Eurpooliin suosituimmista yhtiöistä.